CGS encourages responsible uses and effecitve governance of human genetic and assisted reproductive technologies

Featured

When Might Human Germline Editing Be Justified?

By Jennifer M. Gumer, The Hastings Center | 09.26.2019

Aggregated News

The only type of couple that would be unable to have a healthy, at least partially related, child through existing means is one in which both individuals carry two abnormal genes for the same dominant condition. Given the rarity of such a scenario, the unique benefit of germline editing is extremely limited in its application—a fact that must be emphasized in the discussions surrounding germline editing.
Global Governance

Will Putin Prevent Rebrikov from Attempting Heritable Genome Editing?

By Pete Shanks | 10.08.2019
Biopolitical Times
The Russian molecular biologist who has been threatening to edit the genomes of embryos is getting impatient at the authorities who won't yet let him go ahead. But nothing major happens in Russia nowadays without at least passive consent from the President.
Policies

A New Book Offers an Introduction to the Ethical Dimensions of Germline Gene Editing

By Adam Hayden, Science | 09.30.2019

Aggregated News

With Altered Inheritance, bioethicist Françoise Baylis has authored a vivid call to action that “aims to bridge the divides between theory, science, politics, and practice.”
Human Genetic Modification

Controversial ‘3-Parent Baby’ Fertility Technique Fails to Deliver for Older Women

By Emily Mullin, Medium One Zero [cites CGS' Marcy Darnovsky] | 10.15.2019

Aggregated News

The experimental and much-hyped procedure is not effective at boosting the chances of having a baby for women ages 37 and older.
Assisted Reproduction

Biopolitical Times

Why Has Abuse in the IVF Industry Gone Ignored?

By Pamela Mahoney Tsigdinos | 10.15.2019

A first-of-its-kind workshop titled “Defining Abuse in Assisted Reproductive Technology (ART)” took place on the leafy campus of Kings College...

Assisted Reproduction

Will Putin Prevent Rebrikov from Attempting Heritable Genome Editing?

By Pete Shanks | 10.08.2019

In June, Russian molecular biologist Denis Rebrikov caused a stir by threatening to perform heritable genome editing. At the...

Policies

We’re a Disability Rights Organization, and We Oppose AB 922

By Silvia Yee | 10.04.2019

Why is an organization committed to increasing accessible and equally effective healthcare for people with disabilities asking California Governor Newsom...

Assisted Reproduction

News

Calling Embryo Editing 'Premature,' Russian Authorities Seek to Ease Fears of a Scientist Going Rogue

By Olga Dobrovidova, STAT | 10.16.2019
The Russian health ministry is siding with the World Health Organization's stance against heritable genome editing "until its implications have been properly considered."
Human Genetic Modification

How Big Is the Fertility Services Sector?

By Alison Motluk, Hey Reprotech! | 10.15.2019
The fertility sector is large, and growing. To investors, reproductive vulnerabilities are growth opportunities.  
Assisted Reproduction

Using CRISPR to Edit Eggs, Sperm, or Embryos Does Not Save Lives

By Tina Rulli, STAT | 10.15.2019
It would be much better if we invested the money spent on reproductive CRISPR applications on somatic ones instead.
Human Genetic Modification

Controversial ‘3-Parent Baby’ Fertility Technique Fails to Deliver for Older Women

By Emily Mullin, Medium One Zero [cites CGS' Marcy Darnovsky] | 10.15.2019
The experimental and much-hyped procedure is not effective at boosting the chances of having a baby for women ages 37 and older.
Assisted Reproduction

Video
A Reading and Discussion with George Estreich
Controversial Gene Editing Physicist Missing
Chinese Researcher Claims to Have Genetically Edited Babies